Tribble, D <br/><br/>
Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers.  [electronic resource] 

 -  Vaccine  Aug 2010 
 - 6076-85 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2010.06.086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Adult<br/>Animals<br/>Antibody Formation<br/>Antibody-Producing Cells--immunology<br/>Dysentery, Bacillary--immunology<br/>Female<br/>Guinea Pigs<br/>Humans<br/>Immunity, Mucosal<br/>Immunization Schedule<br/>Immunoglobulin A--blood<br/>Immunoglobulin G--blood<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Shigella Vaccines--adverse effects<br/>Shigella flexneri--immunology<br/>Young Adult